Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,743
Closed -$4.36M 300
2023
Q2
$4.36M Sell
9,743
-1,605
-14% -$808K 0.02% 294
2023
Q1
$5.51M Buy
+11,348
New +$5.61M 0.02% 272
2022
Q4
Sell
-18,489
Closed -$8.97M 661
2022
Q3
$8.97M Sell
18,489
-18,777
-50% -$9.13M 0.03% 177
2022
Q2
$17.4M Buy
37,266
+7,210
+24% +$3.21M 0.07% 99
2022
Q1
$13.1M Buy
+30,056
New +$12.6M 0.05% 126
2021
Q4
Sell
-14,754
Closed -$5.74M 685
2021
Q3
$5.74M Sell
14,754
-8,823
-37% -$3.74M 0.02% 199
2021
Q2
$10.4M Buy
23,577
+2,200
+10% +$961K 0.05% 134
2021
Q1
$8.96M Buy
21,377
+10,027
+88% +$4M 0.04% 120
2020
Q4
$4.66M Buy
11,350
+6,330
+126% +$2.63M 0.02% 169
2020
Q3
$2.08M Buy
5,020
+894
+22% +$360K 0.01% 237
2020
Q2
$1.6M Buy
+4,126
New +$1.54M 0.01% 246

Other funds holding HUM

Brookfield Corp's HUM Position: Q3 2023 in Review

Brookfield Corp sold out of Humana (HUM) in Q3 2023, closing a stake of 9,743 shares — an estimated $4.36M sold.

Brookfield Corp first reported a position in HUM in Q2 2020 and held it in 11 quarters. The position peaked at $17.4M in Q2 2022. 1,087 funds tracked by Wall St. Rank hold HUM as of Q3 2023.

  • Brookfield Corp reported no remaining Humana position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 9,743 Humana shares in Q3 2023, an estimated $4.36M.
  • Brookfield Corp first reported a position in Humana in Q2 2020 and held it in 11 quarters.
  • Brookfield Corp's Humana position peaked at $17.4M in Q2 2022.
  • 1,087 funds tracked by Wall St. Rank held Humana as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.